Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2015 Fourth Quarter And Full Year Financial Results

Go back to Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2015 Fourth Quarter And Full Year Financial Results
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) Delayed: 2.19 +0.04 (1.86%)
Previous Close $2.15    52 Week High $19.62 
Open $2.10    52 Week Low $7.65 
Day High $2.21    P/E N/A 
Day Low $2.06    EPS $-0.22 
Volume 782,623